Cover ImageSALE
Market Research Report

Meningitis Vaccines Market

Published by Research Nester Product code 830896
Published Content info 312 Pages
Delivery time: 1-2 business days
Price
Back to Top
Meningitis Vaccines Market
Published: April 1, 2019 Content info: 312 Pages
Description

Global market of meningitis vaccine stood at USD 12,783.1 Million in 2018 and is expected to reach USD 27,522.5 Million by the end of 2027, expanding at a CAGR of 8.9% over the forecast period i.e. 2019-2027. The advancements in meningitis vaccine and growing healthcare sector globally is anticipated to further boost the demand for meningitis vaccine in future.

Geographically, North America accounted for the largest market share of 41.2% in 2018 in the revenue of meningitis vaccine market globally. The market of North America region is expected to continue its dominance over the forecast period on the back of rising demand for efficient disease preventive Vaccine across the region.

Robust research and development are going on in healthcare sector to manufacture advanced and cost-effective meningitis Vaccine. The advanced meningitis vaccine further provides precise and accurate dosing with minimalist side effects to the vaccinated population.

The adoption of advanced and high end Vaccine is rising in developing regions such as India, China, Japan and others. To gain a competitive edge, different manufacturers of medical equipment have come up with various new Vaccine to effectively aid in the prevention of meningitis.

With USD 5,999.9 Million revenue by the end of 2027 in global market, Asia-Pacific Meningitis Vaccine market is expected to showcase lucrative growth over the forecast period. This growth is primarily attributed on the back of increasing governing regulatory body initiatives in order to reduce the number of deaths caused to meningitis across the region.

With the increasing focus of people on healthcare, the Asia-Pacific meningitis vaccine market is expected to witness rapid growth throughout the forecast period. Asia-Pacific market is expected to expand at a CAGR of 9.4% over the forecast period and expected to contribute a market share of 21.8% in global meningitis vaccine market.

Additionally, favorable government initiatives to develop the healthcare infrastructure coupled with increasing healthcare expenditure across the globe is envisioned to bolster the growth of the meningitis Vaccine market robustly over the forecast period.

Moreover, Europe is estimated to grow at a CAGR of 8.7% over the forecast period contributing a market share of 25.6% in the year 2027 in the global meningitis market.

Some of the leading manufacturers in this market are Sanofi Pasteur, GSK, Pfizer, Merck and Essilor among others.

Table of Contents

1. Introduction

  • 1.1. Market Definition
  • 1.2. Product Overview
  • 1.3. Market Segmentation
  • 1.4. Features by Popular Products Available

2. Assumptions and Acronyms

3. Research Methodology

4. Executive Summary- Global Meningitis Vaccine Market

5. Market Dynamics

  • 5.1. Drivers
  • 5.2. Restraints
  • 5.3. Trends
  • 5.4. Opportunities

6. Risk Analysis

  • 6.1. Demand Risk
  • 6.2. Supply Risk

7. Global Meningitis Vaccine Market Outlook

  • 7.1. Market Size and Forecast, 2018-2027
    • 7.1.1. By Value (USD Million)
      • 7.1.1.1. Y-o-Y Growth (%), 2019-2027
  • 7.2. Market Share and Forecast, 2018-2027
    • 7.2.1. By Vaccine
      • 7.2.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 7.2.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.1.2. Market Attractiveness Analysis, By Vaccine
      • 7.2.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 7.2.2. By Composition
      • 7.2.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 7.2.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.2.2. Market Attractiveness Analysis, By Composition
      • 7.2.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 7.2.3. By End User
      • 7.2.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 7.2.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 7.2.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 7.2.3.2. Market Attractiveness Analysis, By End User
      • 7.2.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 7.2.4. By Region
      • 7.2.4.1. Meningitis Vaccine Market Share (%), By Region (2018,2027F)
        • 7.2.4.1.1. North America
        • 7.2.4.1.2. Europe
        • 7.2.4.1.3. Asia Pacific
        • 7.2.4.1.4. Latin America
        • 7.2.4.1.5. Middle East and Africa

8. North America Meningitis Vaccine Market Outlook

8.1. Macro-Economic Indicators impacting the North America Meningitis Vaccine Market

  • 8.2. Market Size and Forecast, 2018-2027
    • 8.2.1. By Value (USD Million)
      • 8.2.1.1. Y-o-Y Growth (%), 2019-2027

8.3. Market Share and Forecast, 2018-2027

    • 8.3.1. By Vaccine
      • 8.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 8.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 8.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 8.3.2. By Composition
      • 8.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 8.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.2.2. Market Attractiveness Analysis, By Composition
      • 8.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 8.3.3. By End User
      • 8.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 8.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 8.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 8.3.3.2. Market Attractiveness Analysis, By End User
      • 8.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 8.3.4. By Country
      • 8.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 8.3.4.1.1. United States & Canada, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

9. Europe Meningitis Vaccine Market Outlook

  • 9.1. Macro-Economic Indicators impacting the Europe Meningitis Vaccine Market
  • 9.2. Market Size and Forecast, 2018-2027
    • 9.2.1. By Value (USD Million)
      • 9.2.1.1. Y-o-Y Growth (%), 2019-2027

9.3. Market Share and Forecast, 2018-2027

    • 9.3.1. By Vaccine
      • 9.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 9.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 9.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 9.3.2. By Composition
      • 9.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 9.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.2.2. Market Attractiveness Analysis, By Composition
      • 9.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 9.3.3. By End User
      • 9.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 9.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 9.3.3.2. Market Attractiveness Analysis, By End User
      • 9.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 9.3.4. By Country
      • 9.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 9.3.4.1.1. Germany, United Kingdom & France, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.2. Italy, Spain & Turkey, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 9.3.4.1.3. Russia & rest of Europe, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

10. Asia Pacific Meningitis Vaccine Market Outlook

  • 10.1. Macro-Economic Indicators impacting the Asia Pacific Meningitis Vaccine Market
  • 10.2. Market Size and Forecast, 2018-2027
    • 10.2.1. By Value (USD Million)
      • 10.2.1.1. Y-o-Y Growth (%), 2019-2027

10.3. Market Share and Forecast, 2018-2027

    • 10.3.1. By Vaccine
      • 10.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 10.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 10.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 10.3.2. By Composition
      • 10.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 10.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.2.2. Market Attractiveness Analysis, By Composition
      • 10.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 10.3.3. By End User
      • 10.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 10.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 10.3.3.2. Market Attractiveness Analysis, By End User
      • 10.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 10.3.4. By Country
      • 10.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 10.3.4.1.1. India, China and Japan, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 10.3.4.1.2. South Korea, Australia & Rest of Asia Pacific 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

11. Latin America Meningitis Vaccine Market Outlook

  • 11.1. Macro-Economic Indicators impacting the Latin America Meningitis Vaccine Market
  • 11.2. Market Size and Forecast, 2018-2027
    • 11.2.1. By Value (USD Million)
      • 11.2.1.1. Y-o-Y Growth (%), 2019-2027

11.3. Market Share and Forecast, 2018-2027

    • 11.3.1. By Vaccine
      • 11.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 11.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 11.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 11.3.2. By Composition
      • 11.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 11.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.2.2. Market Attractiveness Analysis, By Composition
      • 11.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 11.3.3. By End User
      • 11.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 11.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 11.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 11.3.3.2. Market Attractiveness Analysis, By End User
      • 11.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 11.3.4. By Country
      • 11.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 11.3.4.1.1. Brazil, Mexico & Rest of Latin America, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

12. Middle East and Africa Meningitis Vaccine Market Outlook

  • 12.1. Macro-Economic Indicators impacting the Middle East and Africa Meningitis Vaccine Market
  • 12.2. Market Size and Forecast, 2018-2027
    • 12.2.1. By Value (USD Million)
      • 12.2.1.1. Y-o-Y Growth (%), 2019-2027

12.3. Market Share and Forecast, 2018-2027

    • 12.3.1. By Vaccine
      • 12.3.1.1. Meningitis Vaccine Market Share (%), By Vaccine (2018, 2027F)
        • 12.3.1.1.1. Meningococcal Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.1. MenB, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.2. MenC, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.1.3. MenACWY, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2. Pneumococcal vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.1. PCV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.2.2. PPV, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.1.1.3. Hib, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.1.2. Market Attractiveness Analysis, By Vaccine
      • 12.3.1.3. Market Contribution and BPS Analysis, 2018 & 2027, By Vaccine
    • 12.3.2. By Composition
      • 12.3.2.1. Meningitis Vaccine Market Share (%), By Composition (2018, 2027F)
        • 12.3.2.1.1. Polysaccharide Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.2. Conjugate Vaccine, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.2.1.3. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.2.2. Market Attractiveness Analysis, By Composition
      • 12.3.2.3. Market Contribution and BPS Analysis, 2018 & 2027, By Composition
    • 12.3.3. By End User
      • 12.3.3.1. Meningitis Vaccine Market Share (%), By End User (2018, 2027F)
        • 12.3.3.1.1. Hospitals, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.2. Clinics, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.3. Ambulatory Surgical centers, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.3.1.4. Others, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
      • 12.3.3.2. Market Attractiveness Analysis, By End User
      • 12.3.3.3. Market Contribution and BPS Analysis, 2018 & 2027, By End User
    • 12.3.4. By Country
      • 12.3.4.1. Meningitis Vaccine Market Share (%), By Country (2018,2027F)
        • 12.3.4.1.1. Middle East & Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027
        • 12.3.4.1.1.1. North Africa, South Africa & Rest of Africa, 2018-2027F (USD Million) & Y-o-Y Growth (%), 2019-2027

13. Competitive Landscape

  • 13.1. Competitive Positioning of Major Players in Global Meningitis Vaccine Market
  • 13.2. Company Profiles
    • 13.2.1. GlaxoSmithKline plc
      • 13.2.1.1. Company Overview
      • 13.2.1.2. Business Strategy
        • 13.2.1.2.1. Growth Expansion Strategy
        • 13.2.1.2.2. Distribution Channel Strategy
        • 13.2.1.2.3. Product Strategy
      • 13.2.1.3. Key Product Offerings
      • 13.2.1.4. Financial Performance
      • 13.2.1.5. Key Performance Indicators
      • 13.2.1.6. Risk Analysis
      • 13.2.1.7. Recent Development
      • 13.2.1.8. Regional Presence
      • 13.2.1.9. SWOT Analysis
    • 13.2.2. Pfizer Inc.
    • 13.2.3. Sanofi Pasteur SA
    • 13.2.4. Merck & Co., Inc.
    • 13.2.5. Janssen
    • 13.2.6. Panacea
    • 13.2.7. Hualan Biological Engineering Inc.
    • 13.2.8. Serum Institute of India Ltd.
Back to Top